A qualitative exploration of enablers for hepatitis B clinical management among ethnic Chinese in Australia.


Journal

Journal of viral hepatitis
ISSN: 1365-2893
Titre abrégé: J Viral Hepat
Pays: England
ID NLM: 9435672

Informations de publication

Date de publication:
06 2021
Historique:
received: 26 01 2021
accepted: 22 02 2021
pubmed: 5 3 2021
medline: 2 10 2021
entrez: 4 3 2021
Statut: ppublish

Résumé

An estimated 18% of people living with chronic hepatitis B (CHB) in Australia were born in China. While guideline-based care, including regular clinical monitoring and timely treatment, prevent CHB-related cirrhosis, cancer and deaths, over three-quarters of people with CHB do not receive guideline-based care in Australia. This qualitative study aimed to identify enablers to engagement in CHB clinical management among ethnic Chinese people attending specialist care. Participants self-identified as of Chinese ethnicity and who attended specialist care for CHB clinical management were interviewed in Melbourne in 2019 (n = 30). Semi-structured interviews covered experiences of diagnosis and engagement in clinical management services, and advice for people living with CHB. Interviews were recorded with consent; data were transcribed verbatim and thematically analysed. Receiving clear information about the availability of treatment and/or the necessity of long-term clinical management were the main enablers for participants to engage in CHB clinical management. Additional enablers identified to maintain regular clinical monitoring included understanding CHB increases risks of cirrhosis and liver cancer, using viral load indicators to visualize disease status in patient-doctor communication; expectations from family, peer group and medical professionals; use of a patient recall system; availability of interpreters or multilingual doctors; and largely subsidized healthcare services. In conclusion, to support people attending clinical management for CHB, a holistic response from community, healthcare providers and the public health sector is required. There are needs for public health programmes directed to communicate (i) CHB-related complications; (ii) availability of effective and cheap treatment; and that (iii) long-term engagement with clinical management and its benefits.

Identifiants

pubmed: 33662159
doi: 10.1111/jvh.13495
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

925-933

Subventions

Organisme : Australian National Health and Medical Research Council
Organisme : Melbourne Research Scholarship
Organisme : University of Melbourne Faculty Trust Fellowship

Informations de copyright

© 2021 John Wiley & Sons Ltd.

Références

Maucort-Boulch D, de Martel C, Franceschi S, Plummer M. Fraction and incidence of liver cancer attributable to hepatitis B and C viruses worldwide. Int J Cancer. 2018/06/15 2018;142(12):2471-2477. https://doi.org/10.1002/ijc.31280.
Trépo C, Chan HLY, Lok A. Hepatitis B virus infection. Lancet. 2014;384(9959):2053-2063. https://doi.org/10.1016/s0140-6736(14)60220-8.
WHO. Global Health Sector Strategy on Viral Hepatitis 2016-2021. 2016. https://www.who.int/hepatitis/strategy2016-2021/ghss-hep/en/
European Association for the Study of the Liver. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67:29.
Digestive Health Foundation, Gastroenterological Society of Australia. Australian and New Zealand Chronic Hepatitis B (CHB) Recommendations 2ND Edition 2009/10. https://www.gesa.org.au/resources/clinical-guidelines-and-updates/chronic-hepatitis-b/
MacLachlan J, Smith C, Towell V, Cowie B. Viral Hepatitis Mapping Project: National Report 2018-19. 2020. https://ashm.org.au/programs/Viral-Hepatitis-Mapping-Project/
Department of Health. Third National Hepatitis B Strategy 2018-2022. 2018.
MacLachlan JH, Cowie BC. Cultural and linguistic diversity of people living with chronic hepatitis B in 2011-2016: changing migration, shifting epidemiology. Aust N Z J Public Health. 2018;42(5):441-443. https://doi.org/10.1111/1753-6405.12826.
Cultural and Indigenous Research Centre Australia. Consumer health information needs and preferences: perspectives of culturally and linguistically diverse and Aboriginal and Torres Strait Islander people. 2017.
Vedio A, Liu EZH, Lee ACK, Salway S. Improving access to health care for chronic hepatitis B among migrant Chinese populations: A systematic mixed methods review of barriers and enablers. J Viral Hepatitis. 2017;24(7):526-540. https://doi.org/10.1111/jvh.12673.
Lin W-S, Lee T-T, Yang Y-H, Mills ME. Environmental factors affecting self-management of chronic hepatitis B from the patients’ perspective. J Clin Nurs. 2019/11/01 2019;28(21-22):4128-4138. https://doi.org/10.1111/jocn.14973.
Fang DM, Stewart SL. Social-cultural, traditional beliefs, and health system barriers of hepatitis B screening among Hmong Americans: A case study. Cancer. 2018/04/01 2018;124(S7):1576-1582. https://doi.org/10.1002/cncr.31096.
Wallace J, Pitts M, Liu C, et al. More than a virus: a qualitative study of the social implications of hepatitis B infection in China. Int J Equity Health. 2017;16(1):137. https://doi.org/10.1186/s12939-017-0637-4
Na L, Na B. A revolutionary road: an analysis of persons living with hepatitis B in China. J Health Commun. 2013;18(1):71-91. https://doi.org/10.1080/10810730.2012.688449.
Sievert K, O'Neill P, Koh Y, Lee JH, Dev A, Le S. Engaging new refugee in Australian communities at risk for chronic hepatitis B infection into care: A peer-educator intervention. Health Soc Care Commun. 2018;26(5):744-750. https://doi.org/10.1111/hsc.12602.
Ortiz E, Scanlon B, Mullens A, Durham J. Effectiveness of interventions for hepatitis B and C: a systematic review of vaccination, screening, health promotion and linkage to care within higher income countries. J Commun Health. 2019;45(1):201-218. https://doi.org/10.1007/s10900-019-00699-6.
Robotin MC, George J. Community-based hepatitis B screening: what works? Hepatol Int. 2014;8(4):478-492. https://doi.org/10.1007/s12072-014-9562-4.
Clarke V, Braun V, Terry G, Hayfield N. Thematic Analysis. In: Liamputtong P, ed. Handbook of Research Methods in Health and Social Sciences. Singapore: Springer Singapore; 2019. https://doi.org/10.1007/978-981-10-5251-4_103
Nutbeam D, Harris E, Wise M. Theory in a nutshell: a practical guide to health promotion theories. 2010.
Skinner C, Tiro J, Champion V. The Health Belief Model. In: Glanz K, Rimer B, Viswanath K, eds. Health Behavior : Theory, Research, and Practice. Hoboken, NJ: John Wiley & Sons, Incorporated; 2015.
Members A-HA-PSC. Chronic hepatitis B: treatment alert. Liver Int. 2006/12/01 2006;26(S2):47-58. https://doi.org/10.1111/j.1478-3231.2006.01374.x.
Keeffe EB, Dieterich DT, Han SH, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update. Clin Gastroenterol Hepatol. 2006;4(8):936-962. https://doi.org/10.1016/j.cgh.2006.05.016.
European Association For The Study Of The L. EASL Clinical Practice Guidelines: management of chronic hepatitis B. J Hepatol. 2009;50(2):227-242. https://doi.org/10.1016/j.jhep.2008.10.001.
Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology. 2009;50(3):661-662. https://doi.org/10.1002/hep.23190.
Department of Health. Pharmaceutical Benefits Scheme (PBS). 2020. http://www.pbs.gov.au/pbs/home
Leung AY, Bo A, Hsiao HY, Wang SS, Chi I. Health literacy issues in the care of Chinese American immigrants with diabetes: a qualitative study. BMJ Open. 2014;4(11):e005294. https://doi.org/10.1136/bmjopen-2014-005294
Australian Bureau of Statistics. 2016 Census: Multicultural. Updated 2018. https://www.abs.gov.au/ausstats/abs@.nsf/lookup/MEdia%20Release3

Auteurs

Yinzong Xiao (Y)

Burnet Institute, Melbourne, VIC, Australia.
Department of Gastroenterology, St Vincent's Hospital, Fitzroy, VIC, Australia.
University of Melbourne, Parkville, VIC, Australia.

Jack Wallace (J)

Burnet Institute, Melbourne, VIC, Australia.
La Trobe University, Bundoora, VIC, Australia.

Alex Thompson (A)

Department of Gastroenterology, St Vincent's Hospital, Fitzroy, VIC, Australia.
University of Melbourne, Parkville, VIC, Australia.

Margaret Hellard (M)

Burnet Institute, Melbourne, VIC, Australia.
University of Melbourne, Parkville, VIC, Australia.
School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
Department of Infectious Diseases, The Alfred and Monash University, Melbourne, VIC, Australia.
The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.

Caroline van Gemert (C)

Burnet Institute, Melbourne, VIC, Australia.
University of Melbourne, Parkville, VIC, Australia.

Jacinta A Holmes (JA)

Department of Gastroenterology, St Vincent's Hospital, Fitzroy, VIC, Australia.

Catherine Croagh (C)

Department of Gastroenterology, St Vincent's Hospital, Fitzroy, VIC, Australia.

Jacqui Richmond (J)

Burnet Institute, Melbourne, VIC, Australia.

Tim Papaluca (T)

Department of Gastroenterology, St Vincent's Hospital, Fitzroy, VIC, Australia.
University of Melbourne, Parkville, VIC, Australia.

Samuel Hall (S)

Department of Gastroenterology, St Vincent's Hospital, Fitzroy, VIC, Australia.
University of Melbourne, Parkville, VIC, Australia.

Thai Hong (T)

Department of Gastroenterology, St Vincent's Hospital, Fitzroy, VIC, Australia.

Barbara Demediuk (B)

Department of Gastroenterology, St Vincent's Hospital, Fitzroy, VIC, Australia.

David Iser (D)

Department of Gastroenterology, St Vincent's Hospital, Fitzroy, VIC, Australia.

Marno Ryan (M)

Department of Gastroenterology, St Vincent's Hospital, Fitzroy, VIC, Australia.

Paul Desmond (P)

Department of Gastroenterology, St Vincent's Hospital, Fitzroy, VIC, Australia.

Kumar Visvanathan (K)

Department of Gastroenterology, St Vincent's Hospital, Fitzroy, VIC, Australia.

Jess Howell (J)

Burnet Institute, Melbourne, VIC, Australia.
Department of Gastroenterology, St Vincent's Hospital, Fitzroy, VIC, Australia.
University of Melbourne, Parkville, VIC, Australia.
School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH